New chemo regimen developed for
Hodgkin's lymphoma that is more effective and has fewer side effects.
Bristol Myers Squibb launches a new website -
My CML Care for patients with chronic myeloid leukemia.
Hodgkin's survivors have an
increased risk of stroke and transient ischemic attack.
Scientists have identified the
DNA mutation that begins the development of lymphoma.
Bristol Myers Squibb launches a new website - My CML Care for patients with chronic myeloid leukemia.
Hodgkin's survivors have an increased risk of stroke and transient ischemic attack.
Scientists have identified the DNA mutation that begins the development of lymphoma.